Diammonium hexachloroiridate

Endpoint summary

Description of key information

Skin irritation potential of diammonium hexachloroiridate is determined in a GLP complaint study according to OECD439. Diammonium hexachloroiridate was considered to be non-cytotoxic and predicted to be non-irritant to skin.

Eye irritation potential of diammonium hexachloroiridate is determined in GLP compliant studies according to OECD437 and OECD492.

Based on the outcome of the two in vitro assays, and to avoid further in vivo testing, the registrants agree to classify Diammonium hexachloroiridate as causing serious eye damage (Eye Dam. 1, H318)

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records

Reference

Endpoint:

skin irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

3-19 September 2019

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Remarks:

Study conducted according to GLP

Qualifier:

according to guideline

Guideline:

OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)

Version / remarks:

Reconstructed Human Epidermis Test method

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Specific details on test material used for the study:

Ir content (based on dried sample): 43.22%
Ir content (sample as received): 41.43%

Test system:

human skin model

Source species:

human

Cell type:

non-transformed keratinocytes

Cell source:

other: EpiDermTM (EPI-200, Lot no. 30830) MatTek In Vitro Life Science Laboratories, s.r.o, Mlynské Nivy 73, 821 05 Bratislava II, Slovak Republic

Source strain:

other: Reconstructed human epidermis model (see below)

Details on animal used as source of test system:

Not applicable

Justification for test system used:

The reconstructed human epidermis model system is suitable to test solids, liquids, semi-solids and waxes. The liquids may be aqueous or non-aqueous; solids may be soluble or insoluble in water.

Vehicle:

unchanged (no vehicle)

Details on test system:

The test method is based on reconstructed human epidermis models, which in their overall design (the use of human derived epidermal keratinocytes as cell source, representative tissue and cyto-architecture) closely mimic the biochemical and physiological properties of the upper parts of the human skin, i.e. the epidermis. The procedure described under this test method allows the hazard identification of irritant substances in accordance with UN GHS Category 1 or Category 2.

EpiDerm is a three-dimensional reconstructed human epidermis model EpiDermTM, comprised of normal, human-derived epidermal keratinocytes, which had been cultured to form a multilayered, highly differentiated model of the human epidermis. It consisted of organised basal, spinous and granular layers, and a multilayered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo.

The principle of the reconstructed human epidermis model test is based on the premise that irritant substances are able to penetrate the stratum corneum by diffusion and are cytotoxic to the cells in the underlying layers. Cell viability was measured by dehydrogenase conversion of the vital dye MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Thiazolyl blue), into a blue formazan salt that was quantitatively measured after extraction from tissues. Irritant substances were identified by their ability to decrease cell viability below defined threshold levels (i.e.≤ 50% for UN GHS Category 1 or Category 2).

The EpiDerm™ System was manufactured according to defined quality assurance procedures. All biological components of the epidermis and the culture medium were tested by manufacturer for viral, bacterial, fungal and mycoplasma contamination. MatTek determines the ET50 value following exposure to Triton X-100 (1%) for each EpiDerm lot. The ET50 must fall within a range established based on a historical database of results.

Control samples:

yes, concurrent negative control

yes, concurrent positive control

Amount/concentration applied:

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 25 mg of test item were applied to the skin model and uniformly covered the skin surface with an area of 0.63 cm2. The test item is a fine powder. For better contact of the test item to the skin, the skin surface was moistened with 25 µL Dulbecco’s phosphate buffered saline (D-PBS). Three tissue replicates were used.

NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 25 mg D-PBS .

POSITIVE CONTROL
- Amount(s) applied (volume or weight): 25 mg SDS
- Concentration (if solution): 5% aqueous solution

Duration of treatment / exposure:

Exposure for 60 minutes: 35 minutes at 37°C, 5% CO2 and 95% relative humidity followed by 25 minutes at room temperature under sterile hood.

Duration of post-treatment incubation (if applicable):

The post-treatment incubation period of the rinsed tissues in fresh assay medium was 42 hours.

Number of replicates:

3

Irritation / corrosion parameter:

% tissue viability

Remarks:

Score is a percentage of the negative control

Run / experiment:

mean (42 hour time point)

Value:

92

Vehicle controls validity:

not applicable

Negative controls validity:

valid

Remarks:

The mean optical density (OD) of the negative control of 3 tissues was 1.453 and was well within the acceptable range of ≥ 0.8 to ≤ 2.8.

Positive controls validity:

valid

Remarks:

The viability of cells treated with the positive reference item was 8.7% of the negative control and fulfilled the acceptance criterion of <=20%.

Remarks on result:

no indication of irritation

Remarks:

The mean viability of cells exposed to Diammonium hexachloroiridate was 92% of the negative control and, hence, was above the cut-off percentage cell viability value that distinguishes irritant from non-irritant test items of > 50%. Diammonium hexachloroiridate was considered to be non-cytotoxic and predicted to be non-irritant to skin.

Other effects / acceptance of results:

Assay acceptability criteria:
1: The mean optical density (OD) of 3 negative control tissues was within the acceptable range of ≥0.8 to ≤2.8.
2: The viability of cells treated with the positive reference item fulfilled the acceptance criterion of ≤20%.
3: The assay meets the acceptance criterion if the standard deviation (SD) calculated from individual % tissue viabilities of the 3 identically treated replicates is ≤ 18%.

The mean viability of cells exposed to Diammonium hexachloroiridate was 92% of the negative control and, hence, was above the cut-off percentage cell viability value that distinguishes irritant from non-irritant test items of > 50%. Diammonium hexachloroiridate was considered to be non-cytotoxic and predicted to be non-irritant to skin.

The summary of the results is given below:

	Optical density (n = 3 tissues)	CV (%)	viability (%)		SD
Negative control (D-PBS)	1.453	8.2	100		8.2
diammonium hexachloroiridate	1.337	2.0	92		1.8
Positive control (5% SDS)	0.126	6.8	8.7		0.6

Interpretation of results:

GHS criteria not met

Conclusions:

In an in vitro skin irritation test, using a reconstructed human epidermis model (EpiDermTM), diammonium hexachloroiridate tested at an exposure time of 60 minutes and a 42-hour post-treatment incubation period, did not show irritant properties and is therefore not classified as irritant (UN GHS no category).

Executive summary:

The purpose of this study was to determine whether diammonium hexachloroiridate possesses cytotoxic properties to skin cells, which might lead to irritation of human skin, by using an artificial three-dimensional model of human skin (EpiDermTM model).

Three tissues were used for each treatment and concurrent control group. Cell viability was determined by using the MTT reduction assay and expressed as relative percentage of viability of the negative control-treated tissues.

Diammonium hexachloroiridate was applied topically as solid test item to the model skin surface, which was moistened with Dulbecco's phosphate buffered saline (DPBS). DPBS was used as the negative control. 5% aqueous sodium dodecyl sulphate (SDS) was used as the positive reference item. An exposure time of 60 minutes was employed followed by a 42-hour post-treatment incubation period in fresh medium.

The mean cell viability observed in treated tissues, when compared with that of the concurrent negative control, was above the cut-off cell viability of 50% that distinguishes irritant from non-irritant test items. Diammonium hexachloroiridate is therefore predicted to be non-irritant to skin.

The mean optical density (OD) of 3 negative control tissues was well within the acceptable range of ≥ 0.8 to ≤ 2.8. The viability of cells treated with the positive reference item, 5% SDS, fulfilled the acceptance criterion of ≤ 20%.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records

Reference

Reference 1

Endpoint:

eye irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

4 - 11 Nov 2019

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)

Version / remarks:

adopted 09 October 2017

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)

Version / remarks:

Commission Regulation (EU) No. 2017/735 of 14 February 2017 amending Regulation (EC) No. 440/2008; EC method B.47: Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Specific details on test material used for the study:

Ir content (On dry sample): 43.22% w/w
Ir content (On sample as received): 41.43% w/w

Species:

other: Bovine eyes from cattle

Strain:

not specified

Details on test animals or tissues and environmental conditions:

Source of eyes: Eyes from cattle in the age range of 6 to 12 months were obtained from a slaughterhouse. To minimize deterioration and bacterial contamination, on collection the eyes were completely submerged in Hanks’ Balanced Salt Solution (HBSS) containing penicillin at 100 IU/mL and streptomycin at 100 µg/mL.

Upon arrival at the laboratory, the eyes were examined for defects such as but not limited to increased opacity, scratches, and neovascularisation. Only corneas from eyes free of defects were used.

Vehicle:

physiological saline

Remarks:

The test item was suspension suspended in a 0.9% sodium chloride solution

Controls:

yes, concurrent vehicle

yes, concurrent positive control

Amount / concentration applied:

The test item was suspension suspended in a 0.9% sodium chloride solution with a final concentration of 20% (w/v).

750 µL of the test or control items were added to completely cover the cornea’s epithelium in the anterior chamber.

Duration of treatment / exposure:

240 minutes (recommended exposure time for non-surfactant solids)

Observation period (in vivo):

Not applicable

Number of animals or in vitro replicates:

Not applicable

Details on study design:

SELECTION AND PREPARATION OF CORNEAS: Only corneas from eyes free of defects were used. Corneas that had opacity greater than seven opacity units or equivalent for the opacitometer and cornea holders used after an initial one hour equilibration period had to be discarded. The corneas were dissected with a 2 to 3 mm rim of sclera and mounted in corneal holders with anterior (epithelium) and posterior (endothelium) chambers.Beginning with the posterior chambers, the chambers were filled to excess with pre-warmed Eagle’s Minimum Essential Medium (EMEM) , while preventing bubble formation. The corneal holder was equilibrated at 32 °C ± 1 °C for at least one hour.

QUALITY CHECK OF THE ISOLATED CORNEAS: After the equilibration period, fresh pre-warmed EMEM was added to both chambers and baseline opacity readings were taken for each cornea. Corneas exhibiting macroscopic tissue damage (e.g. scratches, pigmentation, neovascularisation) or an opacity >7 opacity units were discarded. The mean opacity of all equilibrated corneas was calculated by use of an opacitometer. A minimum of three corneaswith opacity values close to the median value for all corneas were selected as negative control corneas. The remaining corneas were then distributed into treatment, solvent and positive control groups (three corneas/group).

NUMBER OF REPLICATES: 3

NEGATIVE CONTROL USED: 0.9% sodium chloride solution

POSITIVE CONTROL USED: 20% Imidazole (CAS no. 288-32-4) in 0.9% sodium chloride solution

TREATMENT METHOD: open-chamber method, 240 minutes exposure period

POST-INCUBATION PERIOD: no

REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: After the exposure period the epithelium was washed with EMEM containing phenol red at least three times. Washing was repeated until no test item or discolouration (yellow or purple) of phenol red was visible. The corneas were rinsed a final time with EMEM only to remove any remaining phenol red from the chamber. After rinsing, the glass window was replaced on the anterior chamber to recreate a closed system and the chamber was filled with EMEM without phenol red.
- POST-EXPOSURE INCUBATION: not applicable

METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Corneal opacity was determined by the amount of light transmission through the cornea measured quantitatively with the aid of an opacitometer resulting in opacity values measured on a continuous scale.
- Corneal permeability: 1 mL sodium fluorescein solution (5 mg/mL in 0.9% sodium chloride solution) was added to the anterior chamber (epithelial surface) while the posterior chamber (endothelial surface) was refilled with fresh EMEM. The holder was incubated in a horizontal position at 32 ± 1 °C for 90 ± 5 minutes. The amount of sodium fluorescein that crossed from the anterior to the posterior chamber was measured quantitatively using a microplate reader. Measurements at 490 nm were recorded as optical density (OD490). The fluorescein permeability values were determined using OD490 values based upon a visible light spectrophotometer using a standard 1 cm path length.
- Others (e.g, pertinent visual observations, histopathology): Corneal injury was assessed by evaluating the opacity and permeability of the cornea.

SCORING SYSTEM: After correcting the opacity and mean permeability (OD490) values for background opacity and the negative control permeability OD490 values, the mean opacity, and permeability OD490 values for each treatment group were combined in an empirically-derived formula to calculate an in vitro irritancy score (IVIS) for each treatment group as follows:
IVIS = mean opacity value + (15 x mean permeability OD490 value)
The opacity and permeability values were also evaluated independently to determine whether the test item induced corrosivity or severe irritation through only one of the two endpoints.

DECISION CRITERIA: The IVIS cut-off values for identifying test chemicals as inducing serious damage (UN GHS Category 1) and test chemicals not requiring classification for irritation or serious eye damage (UN GHS No Category) are given hereafter.

IVIS UN GHS
≤ 3 No Category
>3 and ≤55 No prediction can be made
> 55 Category 1

Irritation parameter:

in vitro irritation score

Run / experiment:

Mean

Value:

3.98

Vehicle controls validity:

valid

Remarks:

IVIS score 0.9% NaCl = 0.553 (SD = 0.551)

Positive controls validity:

valid

Remarks:

IVIS score 20% Imidazol = 92.547 (SD = 28.348)

Remarks on result:

not determinable

Remarks:

The calculated IVIS of 3.980 is above the cut-off value of 3 (UN GHS no category) and below the cut-off value of 55, identifying test substances as inducing serious eye damage (UN GHS Category 1). Consequently, no prediction concerning irritant or severely irritant potential of the test item can be made.

Other effects / acceptance of results:

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Range of historical values if different from the ones specified in the test guideline: see Table 1

The corneas treated with the negative control item 0.9% sodium chloride solution

revealed a mean opacity value of 0.558 ±0.562 and a mean permeability value of

<0.001. The calculated IVIS value of 0.553 ±0.551 was well below the cut-off value of 3

(UN GHS no category).

The corneas treated with the positive control item 20% Imidazole in 0.9% NaCl solution

revealed a mean opacity value of 80.212 ±23.289 and a mean permeability value of

0.822 ±0.359 compared to the solvent control. The calculated IVIS value of 92.547

±28.348 was within two standard deviations of the current historical mean and well above the cut-off value of 55. Hence, the

acceptance criteria for the test were fulfilled.

Following treatment with Diammonium Hexachloroiridate (IV) a mean opacity of 4.010

±0.598 and a mean permeability value of -0.002 ±0.002, compared to the negative

control, were determined. The calculated IVIS of 3.980 ±0.624 is above the cut-off

value of 3 (UN GHS no category) and below the cut-off value of 55, identifying test

substances as inducing serious eye damage (UN GHS Category 1). Consequently, no

prediction concerning irritant or severely irritant potential of the test item can be made.

The IVIS values are given in the table below:

 

	Cornea No.	Opacity	Permeability	IVIS
				Per Cornea	Per Group
					Mean	SD
0.9% NaCl	1	0.478	0.002	0.508	0.553	0.551
	2	0.040	-0.001	0.025
	3	1.155	-0.002	1.125
iridium	4	4.701	0.000	4.701	3.980	0.624
	5	3.665	-0.003	3.620
	6	3.665	-0.003	3.620
20% Imidazol	7	62.430	0.452	69.210	92.547	28.348
	8	106.574	1.168	124.094
	9	71.633	0.847	84.338

SD: standard deviation

OD: optical density

Interpretation of results:

other: no prediction concerning irritant or severely irritant potential of the test item can be made.

Conclusions:

Under the present test conditions Diammonium Hexachloroiridate (IV) tested in the in
vitro BCOP test method, had an IVIS value of 3.980, which is above the cut-off value of
3 (UN GHS no category) and below the cut-off value of 55, identifying test substances
as inducing serious eye damage (UN GHS Category 1). Consequently, no prediction
concerning irritant or severely irritant potential of the test item can be made.

Executive summary:

The eye irritation potential of Diammonium Hexachloroiridate was determined in an in vitro system (Bovine Corneal Opacity and Permeability Assay (BCOP) test method) accodring to OECD test guideline 437. The solid test item was suspended in a 0.9% sodium chloride solution with a final concentration of 20% Diammonium hexachloroiridate.

0.9% NaCl solution was used as the solvent control and 20% Imidazole in 0.9% NaCl solution as the positive control item.

The test item and the controls were applied to the epithelial surface of the cornea by addition to the anterior chamber of the corneal holder. The exposure time for the test item and the controls was 240 minutes. The optical density (OD) was measured at a wavelength of 490 nm.

The acceptance criteria of validity were fulfilled in this test.

Following treatment with Diammonium Hexachloroiridate (IV) a mean opacity of 4.010

±0.598 and a mean permeability value of -0.002 ±0.002, compared to the negative

control, were determined. The calculated IVIS of 3.980 ±0.624 is above the cut-off

value of 3 (UN GHS no category) and below the cut-off value of 55, identifying test

substances as inducing serious eye damage (UN GHS Category 1). Consequently, no

prediction concerning irritant or severely irritant potential of the test item can be made.

Reference 2

Endpoint:

eye irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

17 Feb - 29 April 2020

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)

Version / remarks:

8 June 2019

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Specific details on test material used for the study:

Iridium content: on dry sample 43.22% w/w, on sample as received 41.43% w/w

Species:

other: three-dimensional Reconstructed human Cornea-like Epithelium (RhCE) tissue constructs

Details on test animals or tissues and environmental conditions:

RhCE tissues are reconstructed from primary human cells, which have been cultured for several days to form a stratified, highly differentiated squamous epithelium morphologically similar to that found in the human cornea.

Vehicle:

unchanged (no vehicle)

Controls:

yes, concurrent positive control

yes, concurrent negative control

Amount / concentration applied:

50 mg test item was tested by applying topically on EpiOcular™ tissues

Duration of treatment / exposure:

The tissues with test item applied were incubated at 37°C, 5% CO2 and 95% relative humidity for 6 ± 0.25 hours

Duration of post- treatment incubation (in vitro):

After rinsing and post-soak, each insert is removed and remaining media were decanted, the insert is blotted on absorbent material and transferred to the appropriate well of the pre-labeled 6-well containing 1 mL of warm assay medium. The tissues were incubated at 37°C, 5% CO2 and 95% relative humidity for 18 ± 0.25 hours.

Number of animals or in vitro replicates:

two tissue replicated per treatment, and negative and positive control

Details on study design:

At the end of treatment, test items were removed by extensively rinsing the tissues with DPBS (without Mg2+ and Ca2+) at room temperature (3x dipping tissues in 100mL fresh DPBS).
Afterwards, the tissues were immediately transferred in 5 mL pre-warmed Assay Medium (room temperature) in a pre-labeled 12-well plate for 25 ± 2 minutes.
After the post-soak each insert is removed and remaining media were decanted, the inert is blotted on absorbent material and transferred to the appropriate well of the pre-labeled 6-well containing 1 mL of warm assay medium. The tissues were incubated at 37°C, 5% CO2 and 95% relative humidity for 18 ± 0.25 hours.
After the post-treatment incubation, the MTT assay was performed. For this purpose, tissues were transferred into wells of a 24-well plate containing 0.3 mL of MTT solution (1 mg/mL) . The tissues were incubated at 37°C, 5% CO2 and 95% relative humidity for 180 ± 10 minutes.
After incubation each insert was removed from the 24-well plate. The bottom of the insert was blotted on absorbent material, and then the insert was transferred to a pre labelled 6-well plate containing 1.0 mL of isopropanol in each designated well so that no isopropanol flowed into the insert on the tissue surface. The plates were sealed with parafilm and were immediately extracted on a plate shaker for 3 hours at room temperature in the dark. At the end of the non-submerged extraction, inserts and tissues were discarded without piercing and 1 mL of isopropanol was added into each well. The extract solution was mixed and transferred to a 96-well plate.
The absorbance (Optical Density (OD) at 540 nm) was determined with a microplate reader.
In the pre-tests to determine whether Diammonium Hexachloroiridate (IV) could cause colour interference or directly reduce MTT, the supernatant did not show a blue, purple or black discolouration when suspended in water. The mixture of test item with isopropanol did not show any discolouration, nor did the test item itself directly interact with MTT. Therefore, no quantitative correction of assay results was necessary.

Irritation parameter:

other: viability of the cells

Value:

ca. 8

Vehicle controls validity:

not applicable

Negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

positive indication of irritation

Other effects / acceptance of results:

The mean optical density (OD) of the negative control of 2 tissues was 1.477 and was well within the acceptable range of > 0.8 to < 2.8.
The viability of cells treated with the positive reference item, methyl acetate, was 32.2% of the negative control and below the 50% cut-off value of the negative controls.
Furthermore, the results were within the established historical data.
The percent difference of all replicates determined was below the limit of acceptance of 20%.

summarised results of in vitro eye irritation assay

	mean Optical Density (n=2 tissues)	percent difference tissues 1&2 (%)	viability compared to the control (%)
negative control (deionised water)	1.477	1.7	100
diammonium hexachloroiridate	0.118	5.7	8.0
positive control (methyl acetate)	0.475	1.8	32.2

Interpretation of results:

Category 1 (irreversible effects on the eye) based on GHS criteria

Remarks:

voluntary self-classification by registrants

Conclusions:

Diammonium Hexachloroiridate (IV) is predicted to cause eye irritation since, under the present test conditions using EpiOcular™ RhCE tissue constructs, the mean percent cell viability value obtained was below the cut-off percentage of cell viability (≤ 60%) that distinguishes irritant from non-irritant test items.
Although the test does not allow discrimination between irritancy (UN GHS Category 2) and serious eye damage (UN GHS Category 1), and thus no conclusion regarding the classification of the test item could be made. In order to avoid in vivo testing to descriminate between cat2 and cat 1 classification, the registrants voluntary classify the test item as causing serious eye damage cat 1 (H318).

Executive summary:

The in vitro Eye Irritation Test (OECD Guideline 492) allows the identification of chemical substances and mixtures not requiring classification and labelling for eye irritation or serious eye damage in accordance with UN GHS. The RhCE tissues are reconstructed from primary human cells, which have been cultured for several days to form a stratified, highly differentiated squamous epithelium morphologically similar to that found in the human cornea. EpiOcular™ RhCE tissue constructs (MatTek) were used.

Diammonium Hexachloroiridate (IV) was applied topically to three-dimensional Reconstructed human Cornea-like Epithelium (RhCE) tissue constructs and tissue viability was measured following exposure and a post-treatment incubation period.

Two construct tissues were used for each treatment and concurrent control group. The optical density (OD) was determined by photometrical measurement of formazan production as a result of enzymatic reduction of the vital dye MTT and expressed as relative percentage of viability of the negative control-treated constructs.

50 mg of the test item, 50 µL of the concurrent negative control (sterile deionised water) or 50 µL of the positive control (methyl acetate) were administered by topical application onto the construct as cultures for 6 hours, followed by a 25-minute post-treatment immersion, and an 18-hour post-treatment incubation, prior to the MTT endpoint.

The mean viability of the cells exposed to Diammonium Hexachloroiridate (IV) was 8.0% of the mean negative control value. Hence, the mean percent cell viability value was below the cut-off percentage cell viability value that distinguishes irritant from non-irritant test items of ≤ 60%. Therefore, the test item is predicted to be irritant to the eye.

Based on this result, an in order to avoid in vivo testing to descriminate between cat2 and cat 1 classification, the registrants voluntary classify the test item as causing serious eye damage cat 1 (H318).

Endpoint conclusion

Endpoint conclusion:

adverse effect observed (irreversible damage)

Respiratory irritation

Endpoint conclusion

Endpoint conclusion:

no study available

Justification for classification or non-classification

Diammonium hexachloroiridate does not need classification for skin irritation/corrosion.

Diammonium hexachloroiridate is self-classified by the registrants as Eye Damage 1 (H318).